MEMORANDUM OPINION
Plaintiff Matthew A. Pequignot (“Pequignot”) has filed this action for false patent marking under 35 U.S.C. § 292. In the complaint, Pequignot alleges that defendant Solo Cup Company (“Solo”) falsely marked several of its products with expired patent numbers and improperly marked other products with conditional patent markings. Solo has filed a Motion to Dismiss for Lack of Subject Matter Jurisdiction, arguing that Pequignot lacks standing to bring suit under Article III of the United States Constitution. 1 Alternatively, Solo argues that if Pequignot is found to have standing to sue under § 292(b) as a qui tam relator, maintenance of this action would violate the constitutional separation of powers doctrine, specifically the Take Care clause of Article II, § 3. The United States has intervened to defend the constitutionality of 35 U.S.C. § 292(b). For the reasons stated in open court and in this memorandum opinion, Solo’s motion will be denied.
I. Background
Solo, a Delaware corporation with its principal place of business in Illinois, is a manufacturer of disposable cups, lids, plates, bowls, and utensils. Pequignot is a *716 licensed patent attorney. In his Second Amended Complaint, Pequignot alleges that Solo has committed numerous violations of 35 U.S.C. § 292, which prohibits false patent marking. Specifically, Pequignot alleges that Solo has marked, various products with two patents that have expired, U.S. Patent No. RE28,797, entitled “Lid,” and U.S. Patent No. 4,589,569, entitled “Lid for Drinking Cup.” Pequignot also alleges that Solo has marked several products with the phrase, “This product may be covered by one or more U.S. or foreign pending or issued patents,” when those products were neither protected by any patent nor the subject matter of any pending patent application.
The false marking statute provides that whoever falsely marks a product with either a patent number, the words “patent” or “patent pending,” or any other words or numbers implying that the product is protected by a current or pending patent when it is not, and does so with the intent of deceiving the public, “[sjhall be fined not more than $500 for every such offense.” 35 U.S.C. § 292(a). It further states, “Any person may sue for the penalty, in which event one-half shall go to the person suing and the other to the use of the United States.” 35 U.S.C. § 292(b). Although Pequignot does not, and cannot, allege any particularized injury to himself, he asserts standing based on the literal language of the statute, and seeks the maximum amount of the statutory fine for each alleged violation.
In its Motion to Dismiss, Solo asserts that Pequignot lacks standing to pursue this action under Article III of the United States Constitution, and alternatively, that allowing him to bring suit would violate the constitutional separation of powers doctrine under Article II. 2 Given the United States’ interest in enforcing the false marking statute and its stake in half of the plaintiffs recovery should Pequignot prevail, the Court invited the United States to respond to Solo’s Motion to Dismiss. The United States subsequently intervened and filed a pleading defending the constitutionality of 35 U.S.C. § 292(b). Both parties have submitted responses to the United States’ pleading, and the United States has filed its reply.
II. Standard of Review.
A party invoking federal jurisdiction bears the burden of establishing its existence.
Steel Co. v. Citizens for a Better Env’t,
III. Discussion.
A. Statutory Language.
The statutory provision at issue, 35 U.S.C. § 292(b), is terse. The preceding subsection, 35 U.S.C. § 292(a), defines the substantive false marking violations and penalty:
... Whoever marks upon, or affixes to, or uses in advertising in connection with any unpatented article, the word “patent” or any word or number importing that the same is patented for the purpose of deceiving the public; or
Whoever marks upon, or affixes to, or uses in advertising in connection with *717 any article, the words “patent applied for,” “patent pending,” or any word importing that an application for patent has been made, when no application for patent has been made, or if made, is not pending, for the purpose of deceiving the public—
Shall be fined not more than $500 for every such offense.
35 U.S.C. § 292(a). 3 Section 292(b) then sets forth the remedial scheme at issue here:
Any person may sue for the penalty, in which event one-half shall go to the person suing and the other to the use of the United States.
Two salient features of § 292(b) distinguish it from the vast majority of statutes that establish private rights of action for violations of federal law. First, at least facially, by allowing “any person” to sue for false marking, § 292(b) confers standing on anyone to sue, regardless of whether he or she has been personally affected by the false marking. Second, any recovery by a private party is split, with half going to the person bringing suit, and half going to the United States.
B. Whether Pequignot Has Standing to Sue.
Solo argues that notwithstanding the apparently broad language of § 292(b), Pequignot lacks standing to pursue this action. Solo first argues that the Court should adopt a statutory construction that limits suits under § 292(b) to competitors. It then argues that even if § 292(b) allows suits by non-competitors, Pequignot lacks standing under Article III of the Constitution, either as a traditional plaintiff or as a qui tarn relator.
1. Construction of 35 U.S.C. § 292(b).
Solo urges the Court to avoid the constitutional question by construing § 292(b) narrowly. Under this narrow construction, a suit by a plaintiff like Pequignot, who is not a competitor of the company alleged to have engaged in false patent marking, would be barred. Solo supports this argument by citing to several decisions that have restricted false advertising suits under section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a), to actions by competitors. Solo argues that the Court should adopt a similar limiting construction of § 292(b).
See, e.g., Made in the USA Found, v. Phillips Foods, Inc.,
It is a “cardinal principle” that a court should “first ascertain whether a construction of the statute is fairly possible by which the (constitutional) question(s) may be avoided.”
Johnson v. Robison,
2. Pequignot’s Standing as a Traditional Plaintiff.
Under Article III, a traditional plaintiff must meet three requirements to establish standing to sue in federal court: “injury in fact — a harm that is both concrete and actual or imminent, not conjectural or hypothetical,” “causation — a fairly ... trace[able] connection between the alleged injury in fact and the alleged conduct of the defendant,” and “redressability — a substantial likelihood that the requested relief will remedy the alleged injury in fact.”
Vermont Agency of Natural Res. v. United States ex rel. Stevens,
Although Pequignot has alleged that “every person in the United States is a
potential
entrepreneur ... [and] a
potential
competitor of SOLO CUP,” Compl. ¶ 61 (emphasis added, capitalization in original), any harm to Pequignot in this regard would be the epitome of harm that is “conjectural or hypothetical,” rather than “concrete and actual.”
Vermont Agency,
3. Pequignot’s Standing as a Qui Tam Relator.
Although Pequignot lacks Article III standing as a traditional plaintiff, he and the United States argue that § 292(b) confers standing on him to sue on the United States’ behalf as a qui tam relator,
i. Qui Tam Statutes and Their History.
A
qui tam
statute authorizes a private person, known alternatively as a “relator” or “informer,” to bring suit on behalf of the government and to share in the financial recovery. The phrase
qui tam
is short for the Latin phrase
“qui tam pro domino rege quam pro se ipso in hac parte sequitwr”
meaning “who pursues this action on our Lord the King’s behalf as well as his own.”
Vermont Agency,
Qui tam
actions have a long tradition in early Anglo-American legal history, although their use has waned significantly in recent years.
See generally id.
at 774-78,
Notwithstanding the historical role
qui tam
statutes played, they became subject to abuse. Some citizens, lured by the promise of a financial windfall, became “professional informers.”
Id.
at 575-78 (noting that such individuals were described by contemporaries as “varlets,” “lewde,” “evil,” and “viperous vermin.”). In part as a result of overzealous litigation, many “informer statutes” were repealed, and other statutes were passed to limit their use.
Vermont Agency,
In recent years, the use of
qui tam
statutes to enforce laws has declined dramatically. England repealed its last
qui tam
statutes in 1951.
Id.
at 776,
ii. Standing to Sue in a Qui Tam Action.
Because a
qui tam
statute does not require that the relator suffer an injury before he or she pursues an action, the
qui tam
framework presents a question as to whether a relator has standing to sue under the Constitution. In
Vermont Agency,
the Supreme Court addressed whether a
qui tam
relator under the FCA has Article III standing, and decided the question in the affirmative. The Court ruled that a relator has standing under the doctrine of assignment, holding that “[t]he FCA can reasonably be regarded as effecting a partial assignment of the Government’s damages claim,”
Vermont Agency,
iii. Whether 35 U.S.C. § 292(b) is a Qui Tam Statute.
Solo argues that Vermont Agency is distinguishable from the case at bar because § 292(b) is not truly a qui tam statute and therefore does not effect a partial assignment of the United States’ false marking claims to Pequignot. The overwhelming evidence, however, supports the conclusion that § 292(b) is a qui tam statute, and as such, that Pequignot has standing to maintain this action.
Although it engaged in a long discussion of various qui tam actions throughout history, the Supreme Court in Vermont Agency did not precisely articulate the criteria for a qui tam statute. However, scholarly literature on the subject has identified six elements of a qui tam statute:
*721 (1) The statute defines an offense against the sovereign or proscribes conduct contrary to the interests of the public;
(2) A penalty or forfeiture is imposed for violation of the statute;
(3) The statute permits a civil or criminal enforcement action pursued by a private party;
(4) The private informer need not be aggrieved and may initiate the action in the absence of any distinct, personal injury arising from the challenged conduct;
(5) A successful informer is entitled to a private benefit consisting of part or all of the penalty exacted from the defendant; and
(6) The outcome of the private informer’s enforcement action is binding on the government.
Beck, supra, at 552-53 (citing Blackstone, 3 Commentaries, at *161-62).
Based on these factors, § 292(b) is a qui tam statute. It defines a wrong to the government as the false patent marking in violation of § 292(a). It imposes a statutory penalty of up to $500 per violation. It provides that “any person may sue for the penalty,” regardless of whether or not such a person is personally harmed. Finally, it allows the suing person to receive half of the recovery from the suit, with the remainder going to the government. 9
In addition, the Supreme Court and those courts that have adjudicated cases under § 292 have
explicitly
termed § 292(b) a
qui tam
statute.
See Vermont Agency,
Notwithstanding this highly persuasive authority, Solo advances a number of arguments that § 292(b) is not a
qui tam
statute. First, Solo argues that § 292(b) does not sufficiently clearly assign the rights of the United States because it does not explicitly require a relator to sue “in the name of’ the United States. However, it is well-established that specific terms of art are not required for an assignment of rights.
U.S. ex rel. Kelly v. Boeing Co.,
Solo also argues that § 292(b) is not a qui tam statute because, unlike the FCA, the plaintiff is not paid out of the United States’ recovery; rather, half of any recovery goes directly to the relator and the other half goes to the United States. This formalistic distinction is not a basis for holding that § 292(b) is not a qui tam statute, as other past and present statutes that the Supreme Court has identified as qui tam have provisions similar to § 292(b). See, e.g., 25 U.S.C. § 201 (providing “one half- to the use of the informer and the other half to the use of the United States”); 25 U.S.C. § 81 (repealed 2000) (requiring that “one-half thereof shall be paid to the person suing for the same, and the other half shall be paid into the Treasury”). There is no authority supporting the argument that to qualify as a qui tam statute, the recovery available under that statute must first go to the United States, and only then to the relator. Rather, it is the sharing of the bounty that is a defining feature of a qui tam statute. See Blackstone, 3 Commentaries, at *161 (“Sometimes one part is given to the king, to the poor, or to some public use, and the other part to the informer or prosecutor; and then the suit is called a qui tam action.”)
Solo also argues that § 292(b) cannot be a
qui tam
statute because “the U.S. is not the only party that is able to demonstrate a proprietary injury.” Def.’s Opp. to U.S. Br. 8. This argument is also unavailing. Although the United States must suffer some injury for a
qui tam
action to arise, no authority holds that it must be the
only
party to suffer an injury. Indeed, 25 U.S.C. § 201, one of the
qui tam
statutes identified in
Vermont Agency,
.provides a right to sue for the protection of Indians; this statute clearly contemplates a proprietary injury to a party other than the government. In addition, many of the historical
qui tam
statutes cited in
Vermont Agency
addressed conduct that affected non-governmental proprietary interests, such as horse-stealing, over-charging, and receipt of stolen goods.
See Vermont Agency,
Additionally, Solo argues that the United States’ lack of ability to control a relator’s litigation under § 292(b) undermines the
qui tam
nature of the statute. A number of federal appellate courts have held that the government’s ability to exert control over the litigation is evidence of a
qui tam
statute, and have noted that the FCA provides the government with such control.
See Stalley v. Methodist Healthcare,
Solo’s argument that § 292(b) is not a qui tam statute boils down to a theory that if a statute does not contain all of the features of the FCA, it cannot be a qui tam statute. 13 This argument cannot be reconciled with the numerous statutes— including § 292(b) itself — that the Su *724 preme Court has labeled qui tam despite lacking many of the FCA’s features. 14 Section 292(b) contains many, though not all, of the FCA’s salient features, including a wrong to the government, universal standing, and a shared recovery. Together with the overwhelming authority explicitly describing § 292(b) as a qui tam statute, these factors are more than sufficient to conclude that § 292(b) is indeed a qui tam statute, and therefore, that Pequignot has Article III standing, as a partial assignee of the government’s claims, to sue Solo for violations of § 292. 15
C. Whether § 292 Violates the Constitutional Separation of Powers.
Solo next argues that allowing Pequignot to sue on behalf of the United States as a qui tam relator violates the constitutional separation of powers, specifically the “Take Care” Clause of Article II, which requires that the President “shall take Care that the Laws be faithfully executed.” U.S. Const. Art. II § 3. This provision, which grants the Executive Branch the power to enforce federal law, is part of the scheme of separation of powers, in which Congress passes laws, the President enforces them, and the judiciary interprets them. See, e.g., Riley v. St. Luke’s Episcopal Hospital, 252 F.3d 749, 760 (5th Cir. 2001) (calling the Take Care Clause “a crucial bulwark to the separation of powers”).
The separation of powers can be violated in two basic ways. One involves the “aggrandizement of one branch at the expense of the other,”
Buckley v. Valeo,
Solo argues that § 292(b) impermissibly undermines the Executive Branch because it assigns the ability to enforce the government’s claims for false patent marking to
qui tam
relators without providing the Executive Branch with the ability to control a relator’s litigation. Specifically, Solo argues that Article II is violated because the Executive Branch does not retain “sufficient control” over a § 292
qui tam
suit. The source for the “sufficient control” standard is
Morrison v. Olson,
As in the standing analysis, case law discussing the False Claims Act is relevant to an evaluation of § 292(b). In
Vermont
Agency, the Court explicitly declined to decide the question of whether the
qui tam
provisions of the FCA violate Article II.
See Vermont Agency,
A number of circuit courts, however, have squarely addressed Article II challenges to the FCA. All have affirmed the law’s constitutionality, although based on differing rationales. The Fifth Circuit’s holding was the most sweeping. Like Justices Stevens and Souter, the Fifth Circuit found it “logically inescapable that the same history that was conclusive on the Article III question in
[Vermont Agency
] with respect to
qui tam
lawsuits initiated under the FCA is similarly conclusive with respect to the Article II question concerning this statute.”
Riley,
The Second, Sixth, and Ninth Circuits have also found that the FCA does not violate Article II. However, they rested their holdings more directly on the control mechanisms available to the government, rather than on historical justifications.
16
See U.S. ex. rel. Kelly,
9. F.3d at 755 (finding that “the Executive Branch exer
*726
cises at least an equivalent amount of control over
qui tam
relators as it does over independent counsels”);
U.S. ex rel. Taxpayers Against Fraud v. Gen. Elec. Co.,
Finally, the Tenth Circuit took a fact-specific approach to an Article II challenge to the FCA, and held that “at least where the government intervenes, the
qui tam
provisions of the FCA do 'not violate the separation of powers by transgression of the Take Care Clause.”
U.S. ex rel. Stone v. Rockwell Int’l Corp.,
Solo argues that § 292(b) cannot be constitutional because, unlike the FCA, § 292(b) fails to provide the Executive Branch with sufficient control over the litigation. Unlike the FCA, § 292(b) does not require that the government receive notice of the litigation. Moreover, § 292(b) does not provide the government with the ability to “take over” the litigation from the relator, or to settle or dismiss it over the relator’s objection. Nonetheless, this Court finds that as applied to the facts of this case, § 292(b) does not violate Article II.
First, like Justices Souter and Stevens and the Fifth Circuit, the Court finds the long history of
qui tam
statutes, including many passed by the First Congress soon after the signing of the Constitution,
see, e.g.,
1 Stat. 131, 133, highly persuasive as to their constitutionality.
Qui tam
statutes were part of a long-accepted practice dating back centuries. It is unlikely that the framers would have written a Constitution that outlawed this practice, and then immediately passed several
qui tam
laws that unconstitutionally encroached on Executive Branch power before the ink on the Constitution was even dry. Of course, passage by the First Congress is not dis-positive as to the constitutionality of a law.
See Marbury v. Madison,
5. U.S. (1 Cranch) 137,
Second, it is not necessary for § 292(b) to meet the demanding standard applied by the Supreme Court in
Morrison
to withstand an Article II challenge, given that the intrusion of § 292(b) into Executive Branch power is minor in comparison.
See Riley,
In addition, despite the lack of control mechanisms in § 292(b) itself, the Executive Branch is not without the ability to assert its interests in a § 292(b) qui tam action. The clerks of federal courts are required to notify the Director of the United States Patent and Trademark Office of any patent suits within one month of their filing. See 35 U.S.C. § 290. The United States may intervene in a qui tam action, either as of right, see Fed.R.Civ.P. 24(a)(2), or with a court’s permission, see Fed.R.Civ.P. 24(b). If the United States intervenes and the qui tam relator attempts to voluntarily dismiss the case, it cannot do so without a court order if the United States does not consent. See Fed. R.Civ.P. 41(a)(1)(A)(ii) (allowing dismissal without a court order only if “all parties who have appeared” sign a stipulation of *728 dismissal). Finally, the United States may apply for a protective order if the relator’s action interferes with a government investigation or prosecution. See Fed.R.Civ.P. 26(c). Although these mechanisms concededly do not rise to the same level of government control provided by the FCA, the FCA’s strict safeguards are not required because, as discussed supra, § 292(b) represents a minimal intrusion onto Executive Branch power.
Finally, it is preferable that constitutional challenges be adjudicated as applied.
See U.S. v. Raines,
IV. Conclusion.
It is likely an accident of history that § 292(b) survives as one of only a few remaining qui tam statutes in American law, given that the overwhelming majority of these statutes have been repealed. Unlike false claims against the government, misuse of a patent marking does not involve a proprietary injury to the United States that must be vindicated through the actions of private prosecutors; rather, the injury to the United States is only to its sovereignty. To the extent that there is any real injury caused by false marking, it is to competitors of the entity abusing patent markings. Congress could easily provide such competitors with a private right of action without enacting a qui tam statute. 19 The only practical impact of the qui tam provisions of § 292(b) appears to be its potential to benefit individuals, such as the plaintiff in the case at bar, who have chosen to research expired or invalid patent markings and to file lawsuits in the hope of financial gain.
To the extent that Solo, and other potential defendants in § 292(b) actions, believe that the law is unwise, they ace not without recourse to seek its revision. The history of the FCA, and
qui tam
actions in general, indicates that when these ac
*729
tions have been subject to abuse by profit-seekers with little public motivation, legislatures, both in the United States and England, have reacted. Indeed, in the aftermath of a Supreme Court decision broadly interpreting the FCA,
U.S. ex rel. Marcus v. Hess,
[Pjerhaps Congress should have taken note of the possibility that [defendants] would be harassed by vexatious qui tarn suits in federal courts. Perhaps it did, but decided that the benefits of the qui tarn scheme outweighed its defects. In any event, we have no inclination or power to delve into the wisdom of the balance Congress struck ... Congress has let loose a posse of ad hoc deputies ... [Defendants] may prefer the dignity of being chased only by the regular troops; if so, they must seek relief from Congress.
U.S. ex rel. Milam v. Univ. of Tex. M.D. Anderson Cancer Ctr.,
For the above reasons, the defendant’s Motion to Dismiss will be denied, by an Order to be issued with this opinion.
Notes
. Solo' previously filed a Motion to Dismiss for Failure to State a Claim Pursuant to Fed. R.Civ.P. 12(b)(6), arguing that the alleged violations — marking articles with expired patent numbers or statements that the articles “may be covered” by patents — do not constitute false marking under the statute as a matter of law. In a memorandum opinion, the Court denied that motion.
See Pequignot v. Solo Cup Co.,
. Solo also argues that if Pequignot is found to have standing to pursue this action as an assignee of harm suffered by the United States, he cannot maintain this action as a pro se plaintiff. As Pequignot has since retained counsel, this argument is moot and will not be addressed.
. Section 292(a) also includes language prohibiting marking a product as protected by a particular patent without the consent of the patentee. Because this action does not concern such a violation, this language is omitted here.
. In its opposition to the United States’ brief, Solo cites a recent case,
Mohawk Industries, Inc. v. Interface, Inc.,
No. 4:07-CV-0212-HLM,
. Pequignot notes that “[ajlthough Plaintiff does not concede that he has not been injured, it is Plaintiff’s position that any injury to Plaintiff is redundant to the injury to the United States in this qui tarn cause of action.” PL’s Opp. 4.
. The Supreme Court in Vermont Agency provides a detailed history of qui tam laws in England and the United States. This opinion provides a brief summary.
. Other statutes did not provide for a private right of action, but allowed for an informer to share in the recovery of suits brought by the government.
Id.
at 776 n. 7,
.
Vermont Agency
identified a fourth
qui tam
statute, 25 U.S.C. § 81, which provided a cause of action and a share of recovery for contracting with Indians in an unlawful manner.
Vennont Agency,
. It is unclear whether § 292(b) meets the sixth element outlined by Beck, the binding nature of the enforcement action on the government. The parties in this action dispute whether or not a qui tam relator’s suit would have a res judicata effect on future actions. This issue need not be decided because the absence of this element alone is insufficient to defeat the qui tam nature of § 292(b).
. Safeguards are more relevant to the analysis of whether a qui tam statute violates the Take Care Clause of Article II, as discussed infra.
. Although the First Circuit called procedural safeguards “typical of
qui tam
statutes,”
United Seniors,
. The original FCA, enacted in 1863, contained only one safeguard: once the suit was filed, it could “not be withdrawn or discontinued without the consent, in writing, of the judge of the court and district attorney, first filed in the case, setting forth their reasons for such consent.” Act of Mar. 2, 1863, ch. 67, § 4, 12 Stat. 696, 698 (1863). After the act became subject to abuse by informers who prosecuted cases based on evidence the government already had, Congress amended the FCA to require an informer, upon filing the case, to provide notice to the government and disclose all of his evidence, and to allow the government sixty days to investigate and decide whether to intervene and take control of the suit.
See
Beck,
supra,
at 560; Act of Dec. 23, 1943, ch. 377, 57 Stat. 608 (1943). The 1943 revisions also allowed a court to dismiss a
qui tam
FCA suit if the suit was based on evidence that the government already possessed.
See
Beck,
supra,
at 560;
.Along these lines, Solo also argues that § 292(b) is more analogous to a provision of the Medicare Secondary Payer ("MSP”) statute, 42 U.S.C. § 1395y(b)(3)(A). The MSP statute empowers Medicare to seek reimbursement from primary insurers who are responsible for paying for certain health care costs, and establishes a private right of action for damages. Four circuit courts have held that the MSP statute is not a
qui tam
statute and that only plaintiffs who suffer an injury in fact may sue.
See Stalley,
. Indeed, the logical corollary to Solo's argument that § 292(b) is not a qui tarn statute is that none of the purported qui tam statutes the Court cited are truly qui tam laws.
. In a supplemental brief, Solo argues that the assignment rationale under which qui tam standing was allowed in Vermont Agency should not apply to § 292(b) because § 292(b) purports to assign to relators a governmental interest that is only sovereign in nature — an interest arising from a violation of law — rather than proprietary, as in the case of the FCA, where the government suffers a concrete financial injury. Although some scholars have argued that the government can assign only proprietary, and not purely sovereign, interests, see Myriam E. Gilies, Representational Standing: U.S. ex rel. Stevens and the Future of Public Law Litigation, 89 Cal. L.Rev. 315, 342-44 (2001), the Supreme Court made no such distinction in its discussion of assignment in Vermont Agency, and this Court declines to adopt this distinction.
. These three decisions all predated Vermont Agency, in which the Court announced that the long history of qui tam laws was "well nigh conclusive" on the issue of Article III standing, and in which two justices held that this history was similarly conclusive on the Article II question.
. There is, concededly, some confusion as to whether § 292 is criminal or civil. The Federal Circuit has described § 292 as "supplying] a civil fine,”
Clontech Labs., Inc. v. Invitrogen Corp.,
. Likewise, it is unnecessary to decide whether constitutional issues might arise if, as Solo hypothesizes, multiple relators brought multiple § 292(b) actions for the same underlying violations.
. Indeed, the vast majority of actions brought under § 292 throughout its long history appear to have been brought by competitors or others who could allege an injury to themselves as a result of the false marking.
See, e.g., Mohawk Indus.,
